- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

S. 3011
U.S. Senate•In Senate Committee
Summary
S. 3011, the Prohibiting Abortion & Transgender Procedures on the Exchanges Act, was introduced in the Senate on Oct 15, 2025 by Sen. Josh Hawley (R). It was referred to Health, Education, Labor, And Pensions, and last saw action on Oct 15, 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Record
Text
S. 3011 has no co-sponsors and has not gone to a roll call.
sb3011/introduced-in-senate.txt119 S3011 IS: To amend the Patient Protection and Affordable Care Act to exclude coverage of gender-transition procedures for minors and abortion under health plans offered through the American Health Benefits Exchanges, and for other purposes.U.S. Senate2025-10-15text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.II119th CONGRESS1st SessionS. 3011IN THE SENATE OF THE UNITED STATESOctober 15, 2025Mr. Hawley introduced the following bill;which was read twice and referred to the Committee on Health, Education, Labor, andPensionsA BILLTo amend the Patient Protection and Affordable Care Act to exclude coverageof gender-transition procedures for minors and abortion under health plans offeredthrough the American Health Benefits Exchanges, and for other purposes.1.Short titleThis Act may be cited as the Prohibiting Abortion & Transgender Procedures on the Exchanges Act .2.Exclusion of gender-transition procedures for minors and abortion from coverageunder health plans offered through the American Health Benefits Exchanges(a)In generalSection 1303 of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18023 ) is amended—(1)in subsection (a)—(A)by striking paragraph (2); and(B)by striking the subsection designation and heading and all that follows through A State in paragraph (1) and inserting the following:(a)State opt-Out of abortion coverageA State;(2)in subsection (b), by striking the subsection designation and heading and all that follows through No qualified in paragraph (4) and inserting the following:(b)No discrimination on basis of provision of abortionNo qualified;(3)in subsection (c)—(A)in paragraph (2)—(i)by striking the paragraph designation and heading and all that follows through Nothing in subparagraph (A) and inserting the following:(2)No effect on Federal laws regarding abortionNothing; and(ii)by redesignating clauses (i) through (iii) as subparagraphs (A) through (C), respectively, and adjusting the margins accordingly;(B)by striking the subsection designation and heading and all that follows through the end of paragraph (1) and inserting the following:(c)Application of Federal laws; and(C)by redesignating paragraphs (2) and (3) as paragraphs (1) and (2), respectively;(4)by redesignating subsections (a) through (d) as subsections (b) through (e), respectively; and(5)by inserting before subsection (b) (as so redesignated) the following:(a)Prohibition on coverage of gender-Transition procedures forminors and abortion(1)In generalAn Exchange may not make available any health plan, including any health plan offering excepted benefits (as defined in section 2791(c) of the Public Health Service Act), that provides coverage for—(A)abortion, except in the case where a woman suffers from a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the woman in danger of death unless an abortion is performed, including a life-endangering physical condition caused by or arising from the pregnancy itself, or unless the pregnancy is the result of an act of rape or incest; or(B)gender-transition procedures for minors.(2)DefinitionsIn this subsection:(A)Gender-transition procedure(i)In generalExcept as provided in clause (ii), the term gender-transition procedure means—(I)the prescription or administration of gonadotropin-releasing hormone agonists or any other puberty-blocking drugs for the purpose of changing the body of an individual so that it conforms to the subjective sense of identity of the individual, in the case such identity is at odds with the individual's biological sex of male or female;(II)the prescription or administration of testosterone (when prescribed to a female) or estrogen (when prescribed to a male) for the purpose of changing the body of an individual so that it conforms to the subjective sense of identity of the individual, in the case such identity is at odds with the individual’s biological sex of male or female; or(III)a surgery to change the body of an individual so that it conforms to the subjective sense of identity of the individual, in the case such identity is at odds with the individual’s biological sex of male or female.(ii)ExceptionThe term gender-transition procedure does not include—(I)an intervention described in clause (i) that is performed on—(aa)an individual with biological sex characteristics that are inherently ambiguous, such as those born with 46 XX chromosomes with virilization, 46 XY chromosomes with undervirilization, or having both ovarian and testicular tissue; or(bb)an individual with respect to whom a physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action, for a biological male or biological female;(II)the treatment of any infection, injury, disease, or disorder that has been caused or exacerbated by the performance of an intervention described in clause (i) without regard to whether the intervention was performed in accordance with State or Federal law; or(III)any procedure undertaken because the individual suffers from a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of major bodily function unless the procedure is performed.(B)MinorThe term minor means an individual who has not yet reached 18 years of age..(b)Conforming amendmentSection 1334(a) ( 42 U.S.C. 18054(a) ) is amended—(1)by striking paragraph (6); and(2)by redesignating paragraph (7) as paragraph (6).(c)Effective dateThe amendments made by this section shall apply with respect to plan years beginning on or after January 1, 2026.
Tracker
The tracker indicates the progress of this legislation as it moves through the legislative process.
- Introduced2025-10-15
- Passed Senate
- Passed House
- Conference
- To President
- Became Law
A bill to amend the Patient Protection and Affordable Care Act to exclude coverage of gender-transition procedures for minors and abortion under health plans offered through the American Health Benefits Exchanges, and for other purposes.
Sponsors
Sen. Josh Hawley (R) sponsors S. 3011 alone.
Committees
S. 3011 went before 1 committee: Health, Education, Labor, and Pensions.

Actions
S. 3011 has taken 2 actions since Oct 15, 2025.
| Chamber | Action | |||
|---|---|---|---|---|
Oct 15, 2025 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Health, Education, Labor, and Pensions Committee | ||
Oct 15, 2025 | — | Introduced in Senate |
Votes
S. 3011 has not gone to a roll call.
Titles
S. 3011 goes by 3 titles, 1 of them short titles.
- Prohibiting Abortion & Transgender Procedures on the Exchanges Act — Display Title
- Prohibiting Abortion & Transgender Procedures on the Exchanges Act — Short Title(s) as Introduced
- A bill to amend the Patient Protection and Affordable Care Act to exclude coverage of gender-transition procedures for minors and abortion under health plans offered through the American Health Benefits Exchanges, and for other purposes. — Official Title as Introduced
Lobbying
2 clients hired 2 firms and 11 registered lobbyists who named S. 3011 in 4 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.
Filed under Civil Rights/Civil Liberties, Defense, Education, Family issues/Abortion/Adoption, Foreign Relations, Health Issues, Immigration, Law Enforcement/Crime/Criminal Justice.
Clients
Who paid to be heard, by how many filings named the bill.
| Client | Business | State | Firms | Filings | Reported |
|---|---|---|---|---|---|
| HUMAN RIGHTS CAMPAIGN | — | District of Columbia | 1 | 3 | — |
| SUSAN B ANTHONY LIST | — | Virginia | 1 | 1 | — |
Firms
Registrants who filed on the bill, by filings.
| Registrant | Clients | Filings | Reported |
|---|---|---|---|
| HUMAN RIGHTS CAMPAIGN | 1 | 3 | — |
| SUSAN B ANTHONY LIST | 1 | 1 | — |
Lobbyists
Named on the filings that cite the bill.
| Lobbyist | Firms | Clients | Filings |
|---|---|---|---|
| DAVID STACY | 1 | 1 | 3 |
| JENNIFER BAILEY | 1 | 1 | 3 |
| MATTHEW ROSE | 1 | 1 | 3 |
| AUTUMN CHRISTENSEN | 1 | 1 | 1 |
| BILLY VALENTINE | 1 | 1 | 1 |
| GWEN CHARLES | 1 | 1 | 1 |
| JAMIE DANGERS | 1 | 1 | 1 |
| JEREMY PILZ | 1 | 1 | 1 |
| KATIE GLENN DANIEL | 1 | 1 | 1 |
| MARILYN MUSGRAVE | 1 | 1 | 1 |
| MARJORIE DANNENFELSER | 1 | 1 | 1 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.
| Client | Registrant | Period | Reported | Document |
|---|---|---|---|---|
| SUSAN B ANTHONY LIST | SUSAN B ANTHONY LIST | 2025 fourth_quarter | $420K | 4th Quarter - Report |
| HUMAN RIGHTS CAMPAIGN | HUMAN RIGHTS CAMPAIGN | 2026 second_quarter | $223.7K | 2nd Quarter - Report |
| HUMAN RIGHTS CAMPAIGN | HUMAN RIGHTS CAMPAIGN | 2025 fourth_quarter | $216.2K | 4th Quarter - Report |
| HUMAN RIGHTS CAMPAIGN | HUMAN RIGHTS CAMPAIGN | 2026 first_quarter | $174.3K | 1st Quarter - Report |
Classification
The Congressional Research Service files S. 3011 under Health, one of its 31 policy areas.
CRS Subjects
CRS assigns every bill one policy area from its 31; S. 3011’s is Health.
s3011/policy-areas.txtSource: congress.gov · legiscan.com